Systemic injection of MPTP induced a striking upregulation in TNF-α and IL-1β mRNA levels in the liver (Fig. 5A and B, P < 0.05 versus control), which were markedly suppressed by VSL#3, hMSCs, and cotreatment with them (P < 0.05 versus PD). Here, IL1B is linked to Parkinson disease.